Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: Two very rare conditions in one patient [2]

Annals of Hematology

Volumn 84, Issue 9, 2005, Pages 616-618

  Beck, C ^a   Humpe, A ^a   Harder, S ^a   Schmid, M ^b   Horst, H A ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Allogeneic PBSCT; MDS; Myeloid NK cell precursor leukaemia

Indexed keywords

CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; IDARUBICIN; METHYLPREDNISOLONE; MITOXANTRONE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANEMIA; BLOOD ANALYSIS; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; CANCER GRADING; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CASE REPORT; CHIMERA; CHROMOSOME 20; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL FEATURE; CYTOLOGY; DIAGNOSTIC ACCURACY; DISSEMINATED INTRAVASCULAR CLOTTING; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; LETTER; LEUKEMIA; LEUKOCYTOSIS; LIVER TOXICITY; LIVING DONOR; MALE; MYCOSIS; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; NATURAL KILLER CELL; PNEUMONIA; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; SEPTIC SHOCK; SKIN DEFECT; SPLENECTOMY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FATAL OUTCOME; HUMANS; INFECTION; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID; LEUKEMIA, T-CELL, CHRONIC; MALE; MYELODYSPLASTIC SYNDROMES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION INDUCTION; THROMBOCYTOPENIA; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 23944435699     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1032-6     Document Type: Letter

References (18)

1. Wuchter C, Harbott J, Schoch C, Schnittger S, Borkhardt A, Karawajew L, Ratei R, Ruppert V, Haferlach T, Creutzig U, Dorken B, Ludwig WD (2000) Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1. Leukemia 14:1232-1238
2. Suzuki R, Nakamura S (1999) Malignancies of natural killer (NK) cell precursor: Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res 23:615-624 10.1016/S0145-2126(98)00194-5
3. Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S, Gondo H, Hino N, Mori H, Sugimori H, Kawa K, Oshimi K (2004) Aggressive natural killer-cell leukemia revisited: Large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18:763-770
4. Fernandez LA, Pope B, Lee C, Zayed E (1986) Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line. Blood 67:925-930
5. J Chan K Wong E Jaffe E Ralfkiaer 2001 Aggressive NK-cell leukemia In: ES Jaffe NL Harris H Stein H Vardiman (eds.) World Health Organization classiffication of tumours: Pathology and genetics of tumours of the hematopoietic and lymphoid tissues IARC Press Lyon 198-200
6. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD et al (1994) HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 84:244-255 1:STN:280:ByuB1cbntVM%3D
7. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S (1997) CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity. Blood 90:2417-2428 1:CAS:528:DyaK2sXmtVOqtrk%3D
8. Oshimi K, Yamada O, Kaneko T, Nishinarita S, Iizuka Y, Urabe A, Inamori T, Asano S, Takahashi S, Hattori M et al (1993) Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 7:782-788
9. Urbano-Ispizua A, Schmitz N, de Witte T, Frassoni F, Rosti G, Schrezenmeier H, Gluckman E, Friedrich W, Cordonnier C, Socie G, Tyndall A, Niethammer D, Ljungman P, Gratwohl A, Apperley J, Niederwieser D, Bacigalupo A (2002) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant 29:639-646
10. Ebihara Y, Manabe A, Tanaka R, Yoshimasu T, Ishikawa K, Iseki T, Hayakawa J, Maeda M, Asano S, Tsuji K (2003) Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation. Bone Marrow Transplant 31:1169-1171
11. Hyakuna N, Toguchi S, Higa T, Okudaira T, Taira N, Masuda M, Kitoh T, Ohta T (2004) Childhood blastic NK cell leukemia successfully treated with l-asparagenase and allogeneic bone marrow transplantation. Pediatr Blood Cancer 42:631-634
12. Suminoe A, Matsuzaki A, Takada H, Hattori H, Furuno K, Takemoto M, Maki H, Kanaya N, Ohnuma K, Nishihira H, Hara T (2000) An infant with precursor natural killer (NK) cell leukemia successfully treated with an unrelated cord blood transplantation. Leuk Lymphoma 39:641-646
13. Takami A, Nakao S, Yachie A, Kasahara Y, Okumura H, Miura Y, Sugimori N, Zeng W, Wang H, Kotani T, Shiobara S, Matsuda T (1998) Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 21:1279-1282
14. Tezuka K, Nakayama H, Honda K, Suzumiya J, Oshima K, Kitoh T, Ishii E (2002) Treatment of a child with myeloid/NK cell precursor acute leukemia with l-asparaginase and unrelated cord blood transplantation. Int J Hematol 75:201-206
15. Muroi K, Kawano C, Yokote T, Otsuki T, Kirito K, Komatsu N, Ozawa K (2002) Early myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloid leukemia. Leuk Lymphoma 43:1493-1496
16. Brunstein CG, Hirsch BA, Hammerschmidt D, McGlennen RC, Nguyen PL, Verfaillie CM (2002) Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 29:999-1003
17. Okamoto T, Kanamaru A, Okada M, Kawaguchi K, Saheki K, Takatsuka H, Fujimori Y, Takemoto Y, Kohsaki M, Kakishita E (1996) Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation. Int J Hematol 63:155-160
18. Komeno Y, Kanda Y, Kandabashi K, Kawazu M, Goyama S, Takeshita M, Nannya Y, Niino M, Nakamoto T, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Hirai H (2003) Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol 72:220-222